SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-22-010798
Filing Date
2022-04-27
Accepted
2022-04-27 16:15:03
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 zentalis-registereddirectp.htm 424B5 328686
2 EX-FILING FEES zntl-424b5feetableex107apr.htm EX-FILING FEES 28055
3 logob.jpg GRAPHIC 38416
4 logoc.jpg GRAPHIC 78065
  Complete submission text file 0001628280-22-010798.txt   516701
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255769 | Film No.: 22859730
SIC: 2834 Pharmaceutical Preparations